Nerve growth factor (NGF) induces neurite outgrowth and promotes survival of embryonic sensory and sympathetic neurons. TRKA, a receptor tyrosine kinase cloned from a human colon cancer was later found to be expressed in the nervous system and phosphorylated in response to NGF. Somatic rearrangement(s) of the TRKA gene (also designated NTRK1) are responsible for formation of some oncogenes. Genetic defects in TRKA are responsible for a human disorder, congenital insensitivity to pain with anhidrosis (CIPA). We report here isolation and characterization of the TRKA gene which spans at least 23 kb and is split into 17 exons. Exon sizes range from 18 to 394 bp and intron sizes range from 170 bp to at least 3.3 kb. Sizes and boundaries of the exons were determined, and all the splice donor and acceptor sites conformed to the GT/AG rule. Approximately 1.2 kb of the 5'-flanking regions was sequenced, and putative regulatory elements were identified. These results will be useful for studies on the developmental and biological regulation of the TRKA gene and for further characterization of mutations in CIPA patients as well as elucidation of mechanisms responsible for rearrangement(s) observed in human tumors.
Cell survival, growth and differentiation in nervous systems are mediated by numerous growth factors, including neurotrophic factors (neurotrophins). Nerve growth factor (NGF), the first neurotrophic factor to be discovered, supports the survival of sympathetic ganglion neurons and subpopulations of mainly nociceprive sensory neurons in dorsal root ganglia derived from the neural crest as well as ascending cholinergic neurons of the basal forebrain (Levi-Montalcini, 1987; Thoenen and Barde, 1980) . The TRKA (also named NTRK1) was isolated from a colon carcinoma as a potential new member of the tyrosine kinase gene family (Martin-Zanca et al., 1986) and was later found to be expressed in the nervous system (Martin-Zanca et al., 1990) . TRKA is a receptor tyrosine kinase and is phosphorylated in response to NGF (Kaplan et al., 1991; Klein et al., 1991) .
Congenital insensitivity to pain with anhidrosis (CIPA; McKusick: 256800, also known as congenital sensory neuropathy with anhidrosis, hereditary sensory and autonomic neuropathy type IV) is an autosomal-recessive genetic disease characterized by recurrent episodes of unexplained fever, anhidrosis (absence of sweating) and absence of reaction to noxious stimuli, self-mutilating behavior, and mental retardation (Swanson, 1963i Dyck, 1984 McKusick, 1994) . Recently, we have reported that the gene responsible for CIPA is TRKA, suggesting that the NGF-TRKA system plays a crucial role in development and function of the nociceptive reception as well as establishment of thermoregulation via sweating systems in humans (Indo et al., 1996) .
The TRKA gene is located on the q arm of chromosome 1 (Miozzo et al., 1990; Morris et aL, 1991) . The TRKA-derived oncogenes are also detected in human breast tumor cells (Kozma et al., 1988) or in papillary thyroid carcinoma (Butti et al., 1995; Greco et al., 1995) . These oncogenes are activated by somatic rearrangements juxtaposing their tyrosine kinase domain to the 5'-end sequences derived from unrelated loci and producing chimeric oncogenes whose products display a constitutive and ectopic tyrosine kinase activity. Breakpoints producing some oncogenes often involve a specific region of the TRKA gene and part of its sequence has been described (Greco et al., 1993) . However, the exact location of this region in the whole TRKA gene is unknown, as structure of this gene has not been documented.
We have now defined the structural and genomic organization of TRKA. This knowledge will be useful for studies in developmental and biological regulation of the TRKA gene and further characterization of mutation(s) in CIPA patients and as well as elucidation of mechanisms responsible for rearrangement(s) of TRKA in human tumors.
A phage library constructed from human leukocytes (Clontech, Palo Alto, CA) was screened to obtain DNA fragments from the TRKA gene. We used a human TRKA cDNA (pLM6) (Martin-Zanca et al., 1989) as a radioactively labeled probe and isolated two clones (T6 and T11), covering the entire genomic region of TRKA, as shown in Fig. 1 encoding the intraceUular domain (Indo et al., 1996) . In the present study, all the exon/intron splice junctions were determined by comparing the human TRKA genomic sequences with the human TRKA cDNA sequences. Size of introns was estimated by the sequence of restriction fragments or polymerase chain reaction. The human TRKA gene divided into 17 exons ranged in size from 18 bases (exon 9) to 394 bases (exon 17), and 16 introns ranged in size from 170 bases (intron 9) to at least 3.3 kb (intron I). The entire human TRKA gene was estimated to span at least 23 kb. The sequences of exon-intron boundaries are presented in Table 1 . All of the splice donor and acceptor sites conformed to the GT/AG rule for nucleotides immediately flanking the exon border (Shapiro and Senapathy, 1987) . A single transmembrane domain divides the TRKA protein into an extracellular and an intracellular domain (Snider, 1994; Barbacid, 1995) . The extracellular domain is important for specific NGF binding and includes a signal peptide, three tandem leucine-rich motifs flanked by two cysteine clusters, and two immunoglobulin-like domains (or motifs). The intracellular domains includes a juxtamembrane region, a tyrosine kinase domain, and a very short carboxy-terminal tail (Barbacid, 1995) . We found a general correlation between the genomic organization of the TRKA gene and the functional organization of TRKA protein. Exon 1 contains the signal peptide and the first cysteine cluster. Three leucine-rich motifs are encoded by exons 2, 3 and 4, respectively. This suggests that simple duplication can account for the variable numbers of the motif. Exon 5 contains the second cysteine cluster. The first immunoglobulin-tike motif is encoded by exons 6 and 7, while the second immunoglobulin-like motif is encoded by the single exon 8. Thus, the splice sites of the TRKA gene encoding the extracellular domain separate the functional domains so that each domain is encoded by separate exons. Exon 9 is a small (18-bp) one incorporated into mRNA by alternative splicing and six amino acid residues encoded by this exon are present in the extracellular Table 1 . Exon-intron organization of the human TRKA gene. 
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0 bA small exon incorporated into mRNA of neural tissues by alternative splicing (Barker et al., 1993) .
domain of the neuronal-specific TRKA receptor (Barker et al., 1993) . The transmembrane domain is encoded by exons 10 and 11 and the intracellular domain of TRKA is encoded by exons 11-17. The juxtamembrane domain is encoded by exons 11 and 12. The domain contains an IXNPXpY motif where p indicates phosphorytation at Tyr-490 residue of the activated TRKA (Dikic et al., 1995) . This motif is encoded by exon 12 and is recognized by an Shc adaptor protein required for activation of the Ras-MAPK pathway (Obermeier et al., 1994; Stephens et al., 1994) . The tyrosine kinase domain which is phosphorylated in response to NGF and is critical for the intercellular signaling is encoded by exons 13-17. A consensus sequence motif YXXM which interacts with phosphatidylinositol-3' kinase, is located at the end of the kinase catalytic domain (Tyr-751 residue in TRKA) (Obermeier et al., 1993a; Soltoff et al., 1992) and encoded by exon 17. The short carboxy-terminal tail of 15 amino acids is also encoded by exon 17 and includes a conserved Tyr residue (Tyr-785 in TRKA) which is responsible for binding of phospholipase C), (Obermeier et al., 1993b; Loeb et al., 1994) . Thus, the functional domains or motifs are generally encoded by different exons, except for exons 10 and 1 t which contain a small portion of the transmembrane region and a portion of the juxtamembrane region, respectively.
In addition, there were discrepancies between the nucleotide sequences in exons 7 and 8 of the genomic clone (T6) and those noted in the cDNA (MartinZanca et al., 1989) . A single base substitution of T-871 to G in exon 7 and substitutions of dinucleotide CG (983 and 984) to GC in exon 8 changed codons as follows: Leu-263 to Val and Ser-300 to Cys, respectively. We also found these two substitutions in cDNAs from two normal controls and four CIPA subjects (data not shown). These amino acid changes were located in the immunoglobulinlike motifs 1 and 2, respectively. In rat TRKA cDNA, two amino acids corresponding to these residues are also Val and Cys, respectively (Meakin et al., 1992) . It is noteworthy because this immunoglobulin-like motif-2 is the structural element that determines the interaction of neurotrophins with their receptors (Urfer et al., 1995) . If our data are accurate, two Cys residues should be conserved in the second immunoglobulin-like motif of all human TRK family members as in the first immunogtobulin-like motif (Nakagawara et aL, 1995) .
The nucleotide sequence of 1,226 bp upstream from the base number 1 of the TRKA cDNA (Martin-Zanca et al., 1989) is shown in Fig. 2a . A consensus CAAT or TATA elements were not present upstream of the putative region for transcription initiation. To determine regulatory sites in the TRKA gene, we used a computer program "TFSEARCH" based on a database, "TRANSFAC," which compiled eukaryotic c/s-acting regulatory DNA elements and trans-acting factors (Wingender, 1994) . Sequences from vertebrates were selected on the threshold of 95.0. Sequences similar to the binding site for several transcription factors located between -420 and -990. Sequences homologous to the binding site for the following proteins were seen in this region: c-Rel/NF-xB (Kunsch et al., 1992;  Baeuerle and Henkel, 1994; Schmidt et al., 1996) at position --898, AP-2 (Mitchell et al., 1991; Faisst and Meyer, 1992) at position --852, CdxA (Margalit et al., 1993; Frumkin et al., 1993) at position --809, CCAAT displacement protein (CDP-CR) (Neufeld et al., 1992; Harada et aL, 1995) at position -767, and heat shock transcription factor (HSF) at position --429 (both directions) (Kroeger and Morimoto, 1994) . Determination of the precise putative promoter sites in transcriptional regulation of the TRKA gene is the subject of ongoing study. The nucleotide sequence of the 3' exon region of the gene is shown in Fig. 2b . The site of the polyadenylation signal was inferred from the cDNA. A noncanonical polyadenylation signal was present 21 bases upstream of the polyadenine tail. Oncogenic rearrangements often involve the same region of the TRKA gene, resulting in the same junction. Our study indicates that the region frequently involved in the rearrangements is located in exons 8 through I2 of the TRKA. The structural and genomic organization of the whole human TRKA gene will provide a basis for elucidation of mechanisms responsible for such rearrangement(s). In addition, we found a microsatellite region (GT or CA repeat) located in intron 12. The nucleotide sequence flanking this locus was reported (Greco et al., 1993) and discussed (Butti et al., 1995) . Position of this locus (AFMa127wh9) and data on the heterozygosity were described (Dib et al., 1996) .
Clinically, CIPA is a serious illness that might be fatal in the first years of life if the hyperpyrexia is not properly overcome. In older children, osteomyelitis and bone and/or joint deformities demand surgical procedures sometimes involving extensive amputations (Dyck, 1984; McKusick, 1994) . To data, three different mutations in four families have been identified. A deletion-, a splice-and a missense-mutations all in the region encoding the tyrosine kinase domain were detected in these families. The present study revealed that a single base deletion and missense mutations are located in exon 14 of this gene. Splice mutation is located in the 5"-splice donor site of intron 15. This study will facilitate analyses of CIPA mutations in other regions of TRKA. Identification of such mutations will further genetic diagnoses of this painless but serious disease.
